Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
Express Scripts
Johnson and Johnson
McKesson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020156

See Plans and Pricing

« Back to Dashboard

NDA 020156 describes VIDEX, which is a drug marketed by Bristol Myers Squibb and Bristol-myers Squibb and is included in four NDAs. It is available from one supplier. Additional details are available on the VIDEX profile page.

The generic ingredient in VIDEX is didanosine. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the didanosine profile page.
Summary for 020156
Tradename:VIDEX
Applicant:Bristol-myers Squibb
Ingredient:didanosine
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020156
Medical Subject Heading (MeSH) Categories for 020156
Suppliers and Packaging for NDA: 020156
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VIDEX didanosine FOR SOLUTION;ORAL 020156 NDA Bristol-Myers Squibb Company 0087-6632 0087-6632-41 1 BOTTLE in 1 CARTON (0087-6632-41) > 200 mL in 1 BOTTLE
VIDEX didanosine FOR SOLUTION;ORAL 020156 NDA Bristol-Myers Squibb Company 0087-6633 0087-6633-41 1 BOTTLE in 1 CARTON (0087-6633-41) > 400 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrength10MG/ML
Approval Date:Oct 9, 1991TE:RLD:Yes

Expired US Patents for NDA 020156

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991   Start Trial   Start Trial
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991   Start Trial   Start Trial
Bristol-myers Squibb VIDEX didanosine FOR SOLUTION;ORAL 020156-001 Oct 9, 1991   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Boehringer Ingelheim
Merck
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.